Chordate Medical Holding AB (OSTO:CMH) Enterprise Value: kr-3.81 Mil (As of Jul. 03, 2026) ***


OSTO:CMH Chordate Medical Holding AB OSTO:CMH
46 GF Score
Price kr0.16
GF Value kr26.18
! 6 Warning Signs
View Full Analysis

What is Chordate Medical Holding AB Enterprise Value?

Chordate Medical Holding AB OSTO:CMH -60.40% 46 Enterprise Value is kr-3.81 Mil as of Jul. 03, 2026. GuruFocus rates OSTO:CMH with a GF Score™ of 46/100 and a GF Value™ of kr26.18. The stock has 6 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Chordate Medical Holding AB's Enterprise Value is kr-3.81 Mil. Chordate Medical Holding AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2025 was kr-25.21 Mil. Therefore, Chordate Medical Holding AB's EV-to-EBIT ratio for today is 0.15.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Chordate Medical Holding AB's Enterprise Value is kr-3.81 Mil. Chordate Medical Holding AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 was kr-23.37 Mil. Therefore, Chordate Medical Holding AB's EV-to-EBITDA ratio for today is 0.16.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Chordate Medical Holding AB's Enterprise Value is kr-3.81 Mil. Chordate Medical Holding AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2025 was kr0.99 Mil. Therefore, Chordate Medical Holding AB's EV-to-Revenue ratio for today is -3.84.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Chordate Medical Holding AB's Enterprise Value is kr-3.81 Mil. Chordate Medical Holding AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2025 was kr-24.69 Mil. Therefore, Chordate Medical Holding AB's EV-to-OCF ratio for today is 0.15.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Chordate Medical Holding AB's Enterprise Value is kr-3.81 Mil. Chordate Medical Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2025 was kr-25.77 Mil. Therefore, Chordate Medical Holding AB's EV-to-FCF ratio for today is 0.15.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Chordate Medical Holding AB  (OSTO:CMH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Chordate Medical Holding AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-3.812/-25.214
=0.15

Chordate Medical Holding AB's current Enterprise Value is kr-3.81 Mil.
Chordate Medical Holding AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-25.21 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Chordate Medical Holding AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-3.812/-23.373
=0.16

Chordate Medical Holding AB's current Enterprise Value is kr-3.81 Mil.
Chordate Medical Holding AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-23.37 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Chordate Medical Holding AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-3.812/0.993
=-3.84

Chordate Medical Holding AB's current Enterprise Value is kr-3.81 Mil.
Chordate Medical Holding AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.99 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Chordate Medical Holding AB's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=-3.812/-24.688
=0.15

Chordate Medical Holding AB's current Enterprise Value is kr-3.81 Mil.
Chordate Medical Holding AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-24.69 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Chordate Medical Holding AB's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-3.812/-25.77
=0.15

Chordate Medical Holding AB's current Enterprise Value is kr-3.81 Mil.
Chordate Medical Holding AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-25.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordate Medical Holding AB Enterprise Value Related Terms


Chordate Medical Holding AB Enterprise Value Historical Data

* Premium members only.

The historical data trend for Chordate Medical Holding AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordate Medical Holding AB Enterprise Value Chart

Chordate Medical Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 89.30 28.80 7.42

Chordate Medical Holding AB Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.14 22.12 7.42 1.13 14.82

OSTO:CMH vs ABT, SYK, MDT: Enterprise Value Comparison

For the Medical Devices subindustry, Chordate Medical Holding AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordate Medical Holding AB Enterprise Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Enterprise Value falls into.


OSTO:CMH
46GF Score
Chordate Medical Holding AB OSTO:CMH
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordate Medical Holding AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Chordate Medical Holding AB's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Chordate Medical Holding AB's Enterprise Value for the quarter that ended in Jun. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of kr-3.81 Mil mean?
Chordate Medical Holding AB (OSTO:CMH) has a Enterprise Value of kr-3.81 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Chordate Medical Holding AB and its competitors.
Is Chordate Medical Holding AB's Enterprise Value too high?
Chordate Medical Holding AB's current Enterprise Value is kr-3.81 Mil. Overall, Chordate Medical Holding AB has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Chordate Medical Holding AB's Enterprise Value compare to ABT and SYK?
Chordate Medical Holding AB's Enterprise Value of kr-3.81 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Chordate Medical Holding AB and its competitors. Chordate Medical Holding AB's current Enterprise Value is kr-3.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordate Medical Holding AB stock overvalued right now?
Chordate Medical Holding AB (OSTO:CMH) has a current Enterprise Value of kr-3.81 Mil. The stock's GF Value™ is kr26.18, compared to a current price of kr0.16 — trading 99.4% below its estimated fair value. The current Enterprise Value is kr-3.81 Mil. Chordate Medical Holding AB's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Chordate Medical Holding AB (OSTO:CMH), the current Enterprise Value is kr-3.81 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chordate Medical Holding AB (OSTO:CMH) Overvalued in 2026?

Based on GuruFocus' analysis, Chordate Medical Holding AB stock appears to be undervalued. The current stock price of kr0.16 is trading 99.4% below its estimated GF Value™ of kr26.18.

Key valuation signals for OSTO:CMH:

  • Enterprise Value: kr-3.81 Mil
  • GF Value™: kr26.18 vs. price of kr0.16 (99.4% below fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the OSTO:CMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chordate Medical Holding AB Business Description

Address Farogatan 33, 164 51 Kista, Kista, SWE, 164 40
Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.
46GF Score

Get the complete analysis for OSTO:CMH

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.16
Price
kr26.18
GF Value